Modulation of aggressive behavior in mice by nicotinic receptor subtypes

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Aggression is a common symptom in neuropsychiatric disorders, often leading to poor patient outcomes.
• Current treatments for aggression are limited by efficacy and severe side effects.
• Nicotinic acetylcholine receptors (nAChRs) are implicated in regulating aggression.

Purpose of the Study:

• To investigate the anti-aggressive (serenic) effects of nicotine.
• To determine the specific nAChR subtypes involved in nicotine's serenic effects.
• To differentiate nicotine's effects on aggression from its effects on locomotion.

Main Methods:

• Administered nicotine acutely to three mouse strains (C57BL/6, BALB/c, CD1).
• Used specific nAChR antagonists (methyllycaconitine and dihydro-β-erythroidine) to block receptor activity.
• Administered an α7 nAChR partial agonist (GTS-21) to assess its impact on aggression.

Main Results:

• Nicotine demonstrated dose-dependent reductions in aggression across all tested mouse strains.
• The α7 nAChR antagonist methyllycaconitine blocked nicotine's serenic effects, while the heteromeric antagonist DHβE did not.
• DHβE blocked nicotine's hypolocomotor effects, indicating a dissociation between serenic and locomotor actions.
• GTS-21 also reduced aggression, further implicating α7 nAChRs.

Conclusions:

• Acute nicotine administration exhibits specific anti-aggressive properties.
• The α7 nAChR subtype is critically involved in mediating nicotine's serenic effects.
• Targeting α7 nAChRs may offer a novel therapeutic strategy for pathological aggression.